TheraRadar
Data updated: May 26, 2026

DESFLURANE

Other Approved 2018-02-26

DESFLURANE is indicated for the treatment of Anesthesia.

Source: FDA Label • SHANGHAI HENGRUI
1
Indication
--
Phase 3 Trials
8
Years on Market

Details

Status
Prescription
First Approved
2018-02-26
Routes
INHALATION
Dosage Forms
LIQUID

Companies

Active Ingredient: DESFLURANE

DESFLURANE Approval History

2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2018 to 2024
Nov 2024 SUPPL
Label · Labeling
Sep 2019 SUPPL
Label · Labeling
Feb 2018 ORIGINAL
Update

What DESFLURANE Treats

1 indications

DESFLURANE is approved for 1 conditions since its original approval in 2018. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Anesthesia
Source: FDA Label

DESFLURANE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to DESFLURANE

3 of 11

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
BUPIVACAINE HYDROCHLORIDE
1 shared
Pfizer
Shared indications:
GLYRX-PF
GLYCOPYRROLATE
1 shared
EXELA PHARMA
Shared indications:
MARCAINE HYDROCHLORIDE
BUPIVACAINE HYDROCHLORIDE
1 shared
Pfizer
Shared indications:
📋

Clinical Trial Registry

45 trials
Trial Sponsor ID Phase Status Title
NCT07359508 ONSD 2 AllMS Ph 4 completed Effect of Desflurane v/s Propofol on the Optic Nerve Sheath Diameter
NCT07289945 FWA 00032748 IORG0011243 Ph 3 completed Effects of Sevoflurane vs Desflurane on Early Recovery and Cognitive Function in Elderly Patients Undergoing Scheduled Non-Cardiac Surgery
NCT06779890 TIVolBrain TIVAVolaBrain Ph 4 recruiting Effect of Volatile- Based Versus Total Intravenous Anesthesia on Brain Homeostasis and Neurocognitive Outcome
NCT07123870 KAEK/10.bI.02 Ph 4 recruiting Effect of Combined Intravenous-Inhalational Anesthesia (CIVIA) on Postoperative Recovery Patterns.
NCT05990790 RAPID-II RAPIDII_01 Ph 4 recruiting The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium
NCT03435003 results posted 1074296-3 Ph 4 completed Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
NCT03917186 DESEVAR Ph 4 completed Desflurane vs. Sevoflurane in Endovascular Aortic Repair
NCT05331027 RAPID RAPID_01 Ph 4 completed The Effect of Desflurane Versus Sevoflurane on Postoperative Recovery
NCT02174575 TMDU-1490 Ph 4 withdrawn Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
NCT01219881 results posted 2010H0174 Ph 3 completed Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery
NCT03540030 results posted Pro00021833 Ph 4 completed Opioid-Free Shoulder Arthroplasty
NCT02872389 KBSMC 2016-07-033 Ph 3 completed Power Spectral Analysis of EEG During Equi-MAC Inhalation Anesthesia
NCT02631525 results posted CAAE - 31820014.8.0000.5149 Ph 4 completed Recovery Profile Comparison Between Remifentanil-propofol or Desflurane Anesthesia Monitored With Bispectral Index.
NCT02379715 AJIRB-MED-CT4-14-327 Ph 4 completed Effect-site Concentration of Remifentanil for Smooth Induction With Desflurane
NCT02834845 2016Sept Ph 4 completed Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension
NCT02971254 8174 Ph 2 completed The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients
NCT03209193 OPCAB_SEVO vs DES Ph 4 completed Effect of Anesthetics on Microcirculation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery
NCT04287842 Des-2014E Ph 4 withdrawn Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R
NCT03099616 EC/01/17/1105 Ph 4 completed Automated Closed Loop Propofol Anaesthesia Versus Desflurane Inhalation Anaesthesia In Bariatric Surgery
NCT02335151 2016 -00448 Ph 4 completed CTC Pancreatic Adenocarcinoma
NCT03504033 XeLiv 15-163 Ph 4 withdrawn Xenon-anesthesia on Patients Undergoing Major Liver-resection
NCT02925611 results posted 10313/PG-2Trg/2015/5408-9 Ph 4 completed Comparison of Postoperative Delirium in Patients Anaesthetised With Isoflurane and Desflurane During Spinal Surgery
NCT00762372 results posted BLM-240-003 Ph 2, Ph 3 completed Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)
NCT03727607 2016/1659 Ph 2 completed TIVA Versus Desfluran Anaesthesia in Patients Undergoing Bariatric Surgery
NCT02830243 2016-05-058 Ph 3 completed Comparison of Analgesic Effect of Volatile Anesthetics
NCT02698514 2015-12-023 Ph 3 completed The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics
NCT02609802 2015-09-028 Ph 3 completed The Different Analgesic Potency of Volatile Anesthetics at Equi-MAC
NCT02559297 04-58-23 Ph 2 completed Effects of Sevoflurane and Desflurane on Treg
NCT02987218 INT/IEC/2015/741 Ph 4 completed Comparison of Neuroprotection by Propofol and Desflurane for POCD Following Subarachnoid Hemorrhage Surgery
NCT02322502 14-073 Ph 3 completed Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia
NCT01696630 XENON 2012-002155-41, ET2012-19 Ph 2 completed Xenon Combined With Intraoperative Thoracic Epidural Analgesia
NCT01452256 KEK-ZH Nr.2011-0092 Ph 4 completed Desflurane and Its Effect on Postoperative Morbidity and Mortality in Patients Undergoing Thoracic Surgery
NCT01270620 results posted SU-12062010-7277 IRB: 4593, SPO: 48391 Ph 4 completed Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement
NCT02149628 3-2013-0098 Ph 4 completed The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide
NCT02379546 GaziosmanpashaU-2 Ph 4 completed The Effect of Anaesthesia Depth on Oculo-cardiac Reflex
NCT01167803 XENON PHRC-I/2009/EN-01 2009-017126-39 Ph 4 completed Anesthesia for Obese Patients: Desflurane Versus Xenon
NCT01700907 results posted DES-40-POCD Ph 1, Ph 2 completed Optimization of Desflurane in Elderly Patients
NCT01125982 2009/2171(REK) 2009-017117-30, 09/15863 Ph 4 completed Postoperative Fatigue and Nausea Related to Choice of Anaesthetic Regimens
NCT01886664 Des vs Sevo PRS Ph 4 completed Comparison of PRS According to Inhalation Agent During LDLT
NCT01199237 results posted H10722-35629-01 Ph 4 completed Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block
NCT01924871 results posted deep extubation in CAUH Ph 4 completed Comparison of Deep Extubation During Emergence Using Desflurane or Desflurane With Remifentanil in Patients Undergoing General Anesthesia
NCT01878656 results posted Chung-Ang University Hospital Ph 4 completed Comparison of Emergence Agitation Between Sevoflurane and Desflurane Anesthesia After Orthognathic Surgery
NCT01132157 4-2009-0598 Ph 4 completed Comparison of the Protective Effect of Desflurane and Propofol in Patients With Renal Transplantation
NCT01310582 results posted 19326 Ph 4 completed Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly Females
NCT01833676 901.11 Ph 4 completed To Compare Effect of Sevoflurane Versus Desflurane on the Return of Swallowing Reflexes in the Elderly
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

DESFLURANE FDA Label Details

Indications & Usage

DESFLURANE is indicated for the treatment of Anesthesia.

Looking for the branded version?

SUPRANE

Full clinical data, patents, trials, and competitive landscape for desflurane.

See SUPRANE

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.